Fast Money Traders Share Their Thoughts On Eli Lilly and Co And The Restaurants Sector

Pete Najarian spoke on CNBC's Fast Money about Eli Lilly and Co LLY after the stock dropped 7.77 percent on the news that it terminated its Phase 3 trial of its cardiovascular medicine called evacetrapib. Najarian said that this is a huge blow for the stock, but he would consider buying it if it drops to $77.5, which is its 200-day moving average. Guy Adami commented that the volume in Eli Lilly was huge and that he would also consider buying the stock at $77.5. Tim Seymour spoke about the restaurants. He would be looking for the value in the space and he would avoid high multiple stocks. He named McDonald's Corporation MCD and Yum! Brands, Inc. YUM as the stocks he would consider buying. He would not be a buyer of Buffalo Wild Wings BWLD.